Granules India Gets U.S. FDA Approval for Generic Naproxen

Granules India Ltd. (GRAN) received approval from the U.S. Food and Drug Administration for its naproxen sodium tablet, the generic version of Bayer AG (BAYN)’s Aleve pain relieving medicine, according to a statement on the regulator’s website.

To contact the reporter on this story: Adi Narayan in Mumbai at anarayan8@bloomberg.net

To contact the editor responsible for this story: Niveditha Ravi at nravi2@bloomberg.net

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.